Literature DB >> 11851726

Increased serum interferon alpha in HIV-1 associated lipodystrophy syndrome.

N Christeff1, J-C Melchior, P de Truchis, C Perronne, M-L Gougeon.   

Abstract

BACKGROUND: A syndrome of lipodystrophy (LD) associated with peripheral lipoatrophy and central/visceral adiposity has been reported in HIV-1-infected patients treated by combined antiretroviral therapy (ART). Lipid metabolism is partly regulated by both steroid hormones and cytokines and we have previously reported that dyslipidaemia in LD-positive men is correlated to an increase in cortisol : DHEA ratio (Christeff et al., AIDS 1999;13:2251). In this study we questioned whether it is also related to cytokine perturbations.
MATERIALS AND METHODS: A cross-sectional study was performed on 42 HIV-1-positive men on ART, 27 of whom had symptoms of LD, defined by computed tomography scan. Serum cytokines (IFN-alpha, TNF-alpha, sTNF-RI, sTNF-RII, IL-6, IL-1beta and IL-2) and lipids [cholesterol, triglycerides (TG) and their subclasses], and apolipoproteins (Apo), were determined.
RESULTS: Serum IFN-alpha was markedly increased in LD-positive compared with LD-negative men and controls. IL-6 and TNF-alpha concentrations were also significantly elevated in HIV-positive men compared to controls but the levels of these cytokines did not differ between the two groups of patients. A significant positive correlation was found between accumulation of IFN-alpha and increased levels of cholesterol, TG, VLDL cholesterol, VLDL TG, ApoB and ApoB-ApoA1 ratio. A multivariate forward-performed analysis revealed that IFN-alpha is the best marker for lipid perturbations associated to LD, followed by insulin and cortisol : DHEA ratio.
CONCLUSIONS: This study demonstrates an association between serum IFN-alpha and lipid alterations in LD-positive men. The concomittant action of IFN-alpha and cortisol : DHEA ratio is probably one of the mechanisms responsible for hyperlipidaemia in LD syndrome.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11851726     DOI: 10.1046/j.0014-2972.2001.00940.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  6 in total

Review 1.  [Adverse effects of antiretroviral therapy. Aspects of pathogenesis].

Authors:  U Seybold; R Draenert; F D Goebel
Journal:  Internist (Berl)       Date:  2003-06       Impact factor: 0.743

2.  Low interleukin-10 production is associated with diabetes in HIV-infected patients undergoing antiviral therapy.

Authors:  Daria Trabattoni; Monica Schenal; Miriam Cesari; Eleonora Castelletti; Michela Pacei; Billi Goldberg; Andrea Gori; Mario Clerici
Journal:  Med Microbiol Immunol       Date:  2006-01-26       Impact factor: 3.402

3.  An interferon-alpha-induced tethering mechanism inhibits HIV-1 and Ebola virus particle release but is counteracted by the HIV-1 Vpu protein.

Authors:  Stuart J D Neil; Virginie Sandrin; Wesley I Sundquist; Paul D Bieniasz
Journal:  Cell Host Microbe       Date:  2007-09-13       Impact factor: 21.023

Review 4.  The dawn of precision medicine in HIV: state of the art of pharmacotherapy.

Authors:  Ying Mu; Sunitha Kodidela; Yujie Wang; Santosh Kumar; Theodore J Cory
Journal:  Expert Opin Pharmacother       Date:  2018-09-20       Impact factor: 3.889

5.  Interferon-alpha 2 but not Interferon-gamma serum levels are associated with intramuscular fat in obese patients with nonalcoholic fatty liver disease.

Authors:  Giovanni Tarantino; Susan Costantini; Vincenzo Citro; Paolo Conforti; Francesca Capone; Angela Sorice; Domenico Capone
Journal:  J Transl Med       Date:  2019-01-03       Impact factor: 5.531

6.  Relationship Between Lipodystrophy, Body Composition, Metabolic Profile, and Serum Levels of Adipocytokines.

Authors:  Lívia Bertazzo Sacilotto; Silvia Justina Papini; Adriana Lucia Mendes; Mariana Gatto; Paulo Câmara Marques Pereira; José Eduardo Corrente; Julhiany de Fátima da Silva
Journal:  Front Nutr       Date:  2021-12-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.